David Elkins V sold $2.7M of BMY
EVP, Chief Financial Officer at BRISTOL MYERS SQUIBB CO. 56,000 shares at an average of $47.33, traded Sep 2, 2025, filed Sep 3, 2025.
Score components
- +22RoleCFO
- +25Trade size$2.7M at market
- +10Share of holdings soldSold 25% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000014272-25-000144, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | SOpen-market sale Common Stock, $0.10 par value10b5-1 | -56,000 | $47.33 | $2.7M | 167,379 | Sep 3, 2025 |
Related signals
Other insiders at BRISTOL MYERS SQUIBB CO and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | BMYsell BRISTOL MYERS SQUIBB CO | Cristian Massacesi EVP,Chief Med Offr,Head of Dev | $403k 6,249 shares | -25% | |
| 0Weak | BMYsell BRISTOL MYERS SQUIBB CO | Bartie Wendy Short EVP, Corporate Affairs | $17k 378 shares | -7% | |
| 40Moderate | BMYsell BRISTOL MYERS SQUIBB CO | Benjamin Hickey President, RayzeBio Org. | $3,702 97 shares | -100% | |
| 49Moderate | BMYbuy BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $202k 4,250 shares | +5% | |
| 43Moderate | BRISTOL MYERS SQUIBB CO | Christopher S. Boerner Chief Executive Officer | $110k 2,000 shares | +2% | |
| 33Weak | BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $100k 1,823 shares | +3% | |
| 25Weak | BMYbuy BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $100k 1,830 shares | +3% | |
| 21Weak | BMYsell BRISTOL MYERS SQUIBB CO | Phil M Holzer SVP and Controller | $39k 700 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.